Asian Institute of Gastroenterology
Hyderabad, Telangana, 500032, India
Location status: Recruiting
Location contact
Abhishek Tyagi, M.S.
CONTACT
Abhishek Tyagi, M.S.
PRINCIPAL_INVESTIGATOR
NCT Number: NCT07399652
This prospective study aims to evaluate the performance of a novel Artificial Intelligence (AI) clinical decision support tool during third space endoscopic procedures, such as Endoscopic Submucosal Dissection (ESD) and Peroral Endoscopic Myotomy (POEM).
While these procedures are effective for treating gastrointestinal neoplasms and motility disorders, they carry risks of intraprocedural bleeding and perforation if submucosal blood vessels are not correctly identified and coagulated. Building on previous retrospective validation, this study will assess whether a real-time artificial intelligence model can assist endoscopists in detecting and delineating blood vessels more accurately and faster during live human procedures.
Interested in participating?
Request InfoAll sexes
Interventional
Not applicable
Hyderabad, Telangana, 500032, India
Location status: Recruiting
Abhishek Tyagi, M.S.
CONTACT
Abhishek Tyagi, M.S.
PRINCIPAL_INVESTIGATOR
Background and Rationale
Third-space endoscopy procedures are technically demanding. The primary challenge lies in the inadvertent transection of submucosal vessels, which leads to bleeding that obscures the surgical field and increases the risk of perforation. Currently, vessel identification is entirely operator-dependent.
Our team has developed a deep-learning based artificial intelligence model trained on 250,000 annotated images from 150 POEM procedures. This model is optimized for minimal latency, allowing for real-time visual overlays (delineation) of blood vessels on the endoscopic monitor.
Study Objectives The primary objective is to evaluate the Vessel Detection Rate (VDR)-the proportion of vessels identified by the endoscopist when assisted by the AI compared to standard practice.
The study will also investigate:
Vessel Detection Time (VDT): The latency between a vessel appearing in the field of view and its identification.
Study Design & Workflow:
In this prospective study, the AI system will be integrated into the Olympus EVIS X1 series endoscopy stack. As the endoscopist navigates the submucosal space, the AI will provide real-time visual segmentation masks highlighting vessels. The performance will be recorded and compared against a post-procedure review by independent experts to calculate sensitivity and detection speed.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Real time AI generated segmentation mask or delineation contours for sub-mucosal blood vessels visible on the endoscopy monitor.
Time frame: 3 months
the proportion of vessels identified by the endoscopist
Time frame: 3 months
The latency between a vessel appearing in the field of view and its identification.
Contact information is provided by the study sponsor or research team.
Abhishek Tyagi, M.S.
CONTACT
Mohan Ramchandani, M.D.
CONTACT
Asian Institute of Gastroenterology, India
Other
Artificial Intelligence-Guided Detection of Anatomical Markers to Enhance Safety in Third-Space Endoscopic Procedures
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01793168
1p36 Deletion Syndrome, 3-Methylglutaconic Aciduria, Type V
Sioux Falls, South Dakota, United States
View Trial DetailsNCT06189859
Achalasia, Achalasia Cardia
Cairo, Egypt
View Trial DetailsNCT07620899
Achalasia Cardia, Deglutition Disorders
Hyderabad, Telangana, India
View Trial DetailsNCT07451301
Achalasia Cardia, Deglutition Disorders
Beijing, Beijing Municipality, China
View Trial Details